| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 01/21/2010 | US20100015094 Antiviral nucleoside analogs |
| 01/20/2010 | EP2145965A1 Multiplex quantification of nucleic acids in diseased cells |
| 01/20/2010 | EP2145627A1 Use of uridine in combination with choline for the treatment of memory disorders |
| 01/20/2010 | EP2144921A2 Phosphate modified nucleosides useful as substrates for polymerases and as antiviral agents |
| 01/20/2010 | CN101631796A Compound having structure derived from mononucleoside or mononucleotide, nucleic acid, labeling substance, and method and kit for detection of nucleic acid |
| 01/20/2010 | CN101628927A Method for three-dimensionally selectively preparing Beta-gemcitabine hydrochloride by using 1, 3, 5-3-O-benzoyl-Alpha-D-ribofuranose as raw materials |
| 01/19/2010 | US7648967 Using isoguanosine nucleoside analogs, and derivatives thereof, in cell cultures and in antiviral therapy; increasing the mutation rate of a virus such as bovine viral diarrhea virus and hepatitis C virus |
| 01/19/2010 | CA2466869C Methods and compositions for ameliorating the undesirable effects of chemotherapy |
| 01/14/2010 | WO2010005986A1 Salts of hiv inhibitor compounds |
| 01/14/2010 | WO2010003540A2 A method for the formation of megamitochondria |
| 01/14/2010 | US20100010209 Method and apparatus for combinatorial chemistry |
| 01/14/2010 | US20100010069 Extended Length Borane Phosphonate Nucleic Acid Compounds |
| 01/14/2010 | US20100009902 Glycoconjugation Using Saccharyl Fragments |
| 01/14/2010 | US20100009353 Dye Compounds and the Use of their Labelled Conjugates |
| 01/14/2010 | CA2730153A1 A method for the formation of megamitochondria |
| 01/14/2010 | CA2729769A1 Salts of hiv inhibitor compounds |
| 01/13/2010 | EP2143787A1 A method for the formation of megamitochondria |
| 01/12/2010 | US7645872 Compounds and methods for labeling oligonucleotides |
| 01/12/2010 | US7645745 Propionic Acid (2R,3R,4R,5R)-5-(4-amino-2-oxo-2H-pyrimidin-1-yl)-4-hydroxy-4-methyl-3-propionyloxy-tetrahydro-furan-2-ylmethyl ester; inhibit RNA-dependent RNA viral replication and are useful as inhibitors of HCV NS5B polymerase |
| 01/12/2010 | CA2421040C Methods for synthesizing nucleosides, nucleoside derivatives and non-nucleoside derivatives |
| 01/12/2010 | CA2403835C Anti-viral pyrimidine nucleoside analogues |
| 01/12/2010 | CA2110111C Production of saccharide carboxylic acids |
| 01/07/2010 | WO2010002877A2 Bycyclic nucleosides and nucleotides as therapeutic agents |
| 01/07/2010 | WO2010000459A1 Cyclopropyl polymerase inhibitors |
| 01/07/2010 | WO2009135455A3 Method for producing gemcitabine hydrochloride and intermediate products |
| 01/07/2010 | WO2009105077A3 Methods for preparing modified biomolecules, modified biomolecules and methods for using same |
| 01/07/2010 | US20100004440 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 01/07/2010 | US20100004192 4'-Substituted Nucleoside Derivatives as Inhibitors of HCV RNA Replication |
| 01/07/2010 | US20100003213 4'-substituted nucleoside derivatives as inhibitors of hcv rna replication |
| 01/07/2010 | CA2729316A1 Cyclopropyl polymerase inhibitors |
| 01/06/2010 | EP2141244A1 Multiplex quantification of nucleic acids in diseased cells |
| 01/06/2010 | EP2141172A1 Cyclopropyl polymerase inhibitors |
| 01/06/2010 | EP2139884A1 Process for preparing of 2'-deoxy-2'2'-difluorocytidine |
| 01/06/2010 | EP1476573B1 Crude biological derivatives competent for nucleic acid detection |
| 01/06/2010 | CN101619087A Method for modifying and synthesizing nucleoside compound |
| 01/06/2010 | CN101619086A Disodium 5'-ribonucleotide crystal and preparation method thereof |
| 01/06/2010 | CN100577679C L-nucleoside prodrug |
| 01/05/2010 | US7642344 Determination of multiple nucleic acid sequences simultaneously; obtain sample, incubate with labeled probe, separate labeled nucleotide sequences, remove label, detect labels |
| 01/05/2010 | US7642247 1,3,5-triazines for treatment of viral diseases |
| 01/05/2010 | CA2358923C Water-soluble rhodamine dyes and conjugates thereof |
| 12/31/2009 | US20090326214 Crystalline Polymorphs of Gemcitabine Base |
| 12/31/2009 | US20090326213 Process for production of crystal of purine nucleoside compound |
| 12/31/2009 | US20090325896 Partial and full agonists of a1 adenosine receptors |
| 12/31/2009 | US20090325260 Cis reactive oxygen quenchers integrated into linkers |
| 12/31/2009 | US20090325172 sequencing reactions where nucleotide or nucleoside molecules modified by reversible covalent attachment of 3'-OH blocking groups thereto, are used where blocked nucleotide or nucleoside molecules are required |
| 12/31/2009 | US20090324708 Compound having inhibitory activity on a rho-gtpase cell protein, a process for obtaining the same, pharmaceutical compositions comprising thereof and a method for the treatment of rho-gtpase cell protein-mediated condition |
| 12/30/2009 | WO2008154639A3 Improved process for the production of nucleotide sugars |
| 12/30/2009 | EP2137202A1 Process for the synthesis of ib-meca |
| 12/30/2009 | EP2137201A2 Process for preparing capecitabine |
| 12/30/2009 | EP0804561B1 Regulated transcription of targeted genes and other biological events |
| 12/30/2009 | CN101613391A 3-(D-glucopyranosyl) thiazole derivative, preparation method and application thereof |
| 12/30/2009 | CN101613390A Method for separating and purifying high-purity cordycepin |
| 12/29/2009 | US7638528 Drug delivery agent containing an anticarcinogenic agent such as mitoxanthrone, doxorubicin, methotrexate etc. covalently linked to a compound via an ester, amido or carabamte linkage to the S, O or amino group of the compound |
| 12/29/2009 | US7638502 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation |
| 12/29/2009 | US7638500 Brevenal derivatives; used to treat diseases characterized by decreased mucus clearance or mucociliary dysfunction such as cystic fibrosis; COPD and asthma; and to treat brevetoxin and ciguatoxin poisoning |
| 12/29/2009 | US7638279 Preferential nucleotide sequences for use in in the detection, quantitation and/or analysis of nucleic acids |
| 12/29/2009 | CA2425663C Fluorescent nucleobase conjugates having anionic linkers |
| 12/29/2009 | CA2339054C E-isomeric fullerene derivatives |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090318556 Biomarkers for detecting radiation exposure: methods and uses thereof |
| 12/24/2009 | US20090318538 Polymeric oligonucleotide prodrugs |
| 12/24/2009 | US20090318380 2',4'-substituted nucleosides as antiviral agents |
| 12/24/2009 | US20090317361 Carba-nucleoside analogs for antiviral treatment |
| 12/23/2009 | WO2009154276A1 Crystal of spiroketal derivative, and process for production thereof |
| 12/23/2009 | WO2009069095A3 Antiviral nucleoside compounds |
| 12/23/2009 | EP2134736A1 Five- and six-membered conformationally locked 2',4'- carbocyclic ribo-thymidines for the treatment of infections and cancer |
| 12/23/2009 | EP2134735A1 Magnetic bead trap and mass spectrometer interface |
| 12/23/2009 | CN101611046A Antiviral nucleoside analogs |
| 12/23/2009 | CN101606947A Gemcitabine hydrochloride composition and preparation method thereof |
| 12/23/2009 | CA2727923A1 Crystal of spiroketal derivatives and process for preparation of spiroketal derivatives |
| 12/22/2009 | US7635762 Luminescent metal ion complexes |
| 12/22/2009 | US7635691 Use of CDP-choline for the prophylactic treatment of cerebral ischemia |
| 12/22/2009 | US7635578 Sequencing; solid phase synthesis; primer hybridization |
| 12/22/2009 | CA2479674C New therapeutic use of 5-aminoimidazole-4-carboxamide riboside (acadesine) |
| 12/22/2009 | CA2407559C Process for the preparation of pharmaceutically acceptable salts of (ss-rs)-s-adenosyl-l-methionine |
| 12/22/2009 | CA2145761C Nucleic acid ligands and methods for producing the same |
| 12/22/2009 | CA2114221C 1, 3-oxathiolane nucleoside analogues |
| 12/17/2009 | WO2009152431A1 P2y1 receptor antagonists |
| 12/17/2009 | WO2009152421A1 Crystalline polymorphs of gemcitabine base |
| 12/17/2009 | WO2009152353A2 Nucleotides and nucleosides and methods for their use in dna sequencing |
| 12/17/2009 | WO2009151921A1 Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid |
| 12/17/2009 | CA2727813A1 Crystalline polymorphs of gemcitabine base |
| 12/17/2009 | CA2727709A1 Nucleotides and nucleosides and methods for their use in dna sequencing |
| 12/17/2009 | CA2727495A1 Nucleoside cyclicphosphates |
| 12/17/2009 | CA2725239A1 Chemically modified nucleoside 5'-triphosphates for thermally initiated amplification of nucleic acid |
| 12/16/2009 | EP2132216A1 Novel nucleoside analogs for treatment of viral infections |
| 12/16/2009 | EP2132215A2 Compounds for preventing or treating viral infections and methods of use thereof |
| 12/16/2009 | EP0824541B1 Nucleic acid ligand complexes |
| 12/16/2009 | CN101602786A N*-substituted adenosine derivative, preparation method thereof, drug composition and application |
| 12/16/2009 | CN100569790C Synthesis of N-acyl-5'-desoxy-5-flucytogly derivative |
| 12/15/2009 | CA2481078C Method and compositions for the synthesis of bch-189 and related compounds |
| 12/15/2009 | CA2339008C Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases |
| 12/15/2009 | CA2276306C Loss of imprinting-based in vitro diagnostic method to determine the propensity to develop cancer |
| 12/10/2009 | US20090306360 2-azaadenine bases form specific base pairs with guanine; when used to substitute cytosine in oligonucleotides leads specifically to hybridization complexes with nucleic acids with homogenous stability; 3-(2-Deoxy- beta -D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]purine (1,N6-Etheno-2'-deoxyadenosine, 5) |
| 12/10/2009 | US20090306010 P1-(2'-deoxycytidine 5'-)p4-(uridine 5'-)tetraphosphate, tetra-(alkali metal) salt, for treating disorders |
| 12/10/2009 | US20090306008 3'-ethynylcytidine derivative |
| 12/10/2009 | US20090306007 Nucleosides with antiviral and anticancer activity |
| 12/10/2009 | US20090306000 Tanaproget derivatives, metabolites, and uses thereof |
| 12/10/2009 | US20090305433 Water-Soluble Rhodamine Dye Conjugates |
| 12/09/2009 | CN101600726A Novel nucleoside analogs for treatment of viral infections |